Thrombolytic Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
Condition:   Ischemic Stroke Interventions:   Drug: mutant pro-urokinase;   Drug: Alteplase Sponsor:   Erasmus Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials

Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
Condition:   Ischemic Stroke Interventions:   Drug: mutant pro-urokinase;   Drug: Alteplase Sponsor:   Nadinda van der Ende Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials

Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
Condition:   Ischemic Stroke Interventions:   Drug: mutant pro-urokinase;   Drug: Alteplase Sponsor:   Erasmus Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials